NEW YORK (GenomeWeb) – The US Department of Veterans Affairs has launched a large, randomized clinical trial to assess whether using Myriad Genetics' GeneSight pharmacogenetic test helps get patients with major depressive disorder to the right treatment and improves their outcomes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.